Frequent weight gain and loss can stress the skin and affect its elasticity
The KFF 2025 Employer Health Benefits Survey then showed an even sharper acceleration: 43% of firms with 5,000+ workers now cover GLP-1s for weight loss, up from just 28% in 2024 ( [6] )
For instance, a phase II trial in ulcerative colitis patients was mentioned in abstracts
Some individuals may transition to more affordable therapies or rely more heavily on lifestyle changes if insurance no longer covers the medication
The Foundayo approval was conducted under the FDAs The approval followed two randomized, double-blind, placebo-controlled trials in adults who have obesity or overweight with one or more weight-related comorbidities
The $10 billion price rested on optimistic assumptions about Metseras future performance, estimating Pfizer would need to generate about $11 billion in revenue from the deal by 2040 nearly double Metseras current projections, Courtney Breen, an analyst at Bernstein, said